JP2024529918A - 結腸直腸がんの検出のための組成物および方法 - Google Patents

結腸直腸がんの検出のための組成物および方法 Download PDF

Info

Publication number
JP2024529918A
JP2024529918A JP2024503595A JP2024503595A JP2024529918A JP 2024529918 A JP2024529918 A JP 2024529918A JP 2024503595 A JP2024503595 A JP 2024503595A JP 2024503595 A JP2024503595 A JP 2024503595A JP 2024529918 A JP2024529918 A JP 2024529918A
Authority
JP
Japan
Prior art keywords
polypeptide
antigen
biomarker
target
biomarkers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024503595A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024529918A5 (cg-RX-API-DMAC7.html
Inventor
ジョゼフ チャールズ セドラック,
エミリー スーザン ウィン-ディーン,
ダニエル グーセンライトナー,
アンソニー デイビッド クービロン,
ローラ テレサ ボートリン,
ダニエル パーカー セイラム,
ケリー ビエット,
サンチャリ バネルジー,
Original Assignee
マーシー バイオアナリティクス, インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マーシー バイオアナリティクス, インコーポレイテッド filed Critical マーシー バイオアナリティクス, インコーポレイテッド
Publication of JP2024529918A publication Critical patent/JP2024529918A/ja
Publication of JP2024529918A5 publication Critical patent/JP2024529918A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2024503595A 2021-07-21 2022-07-21 結腸直腸がんの検出のための組成物および方法 Pending JP2024529918A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163224378P 2021-07-21 2021-07-21
US63/224,378 2021-07-21
PCT/US2022/037931 WO2023004077A2 (en) 2021-07-21 2022-07-21 Compositions and methods for detection of colorectal cancer

Publications (2)

Publication Number Publication Date
JP2024529918A true JP2024529918A (ja) 2024-08-14
JP2024529918A5 JP2024529918A5 (cg-RX-API-DMAC7.html) 2025-07-30

Family

ID=84978808

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024503595A Pending JP2024529918A (ja) 2021-07-21 2022-07-21 結腸直腸がんの検出のための組成物および方法

Country Status (5)

Country Link
US (1) US20240344139A1 (cg-RX-API-DMAC7.html)
EP (1) EP4373962A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024529918A (cg-RX-API-DMAC7.html)
CA (1) CA3227148A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023004077A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250101529A1 (en) * 2023-09-25 2025-03-27 Mercy Bioanalytics, Inc. Multimodal detection with extracellular vesicles

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140228233A1 (en) * 2011-06-07 2014-08-14 Traci Pawlowski Circulating biomarkers for cancer
US20160041153A1 (en) * 2008-11-12 2016-02-11 Kirk Brown Biomarker compositions and markers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12631624B2 (en) * 2018-10-23 2026-05-19 Meso Scale Technologies, Llc. Methods for isolating surface marker displaying agents
CA3129868A1 (en) * 2019-03-01 2020-09-10 Mercy Bioanalytics, Inc. Systems, compositions, and methods for target entity detection

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160041153A1 (en) * 2008-11-12 2016-02-11 Kirk Brown Biomarker compositions and markers
US20140228233A1 (en) * 2011-06-07 2014-08-14 Traci Pawlowski Circulating biomarkers for cancer

Also Published As

Publication number Publication date
EP4373962A4 (en) 2025-12-31
CA3227148A1 (en) 2023-01-26
EP4373962A2 (en) 2024-05-29
US20240344139A1 (en) 2024-10-17
WO2023004077A3 (en) 2023-04-06
WO2023004077A2 (en) 2023-01-26

Similar Documents

Publication Publication Date Title
US20240368701A1 (en) Compositions and methods for cancer detection
JP7344973B2 (ja) 標的実体を検出するためのシステム、組成物、及び方法
US20240011993A1 (en) Compositions and methods for detection of lung cancer
US20230243834A1 (en) Compositions and methods for detection of ovarian cancer
US20250297317A1 (en) Compositions and methods for detection of liver cancer
WO2023004083A2 (en) Compositions and methods for detection of bile duct cancer
US20250223649A1 (en) Compositions and methods for detection of lung cancer
US20250043357A1 (en) Compositions and methods for detection of esophageal cancer
US20240377401A1 (en) Compositions and methods for detection of prostate cancer
US20240369558A1 (en) Compositions and methods for detection of breast cancer
US20240344139A1 (en) Compositions and methods for detection of colorectal cancer
US20240369560A1 (en) Compositions and methods for detection of pancreatic cancer
JP2024543085A (ja) 卵巣がんの検出のための組成物および方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250722

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250722

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260702